Matthew M. Meyerson

机构：Broad Institute, Massachusetts Institute of Technology · ORCID：0000-0002-9133-8108

发表论文 1744 篇 · 总被引 275010 次 · h-index 211

代表论文

PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestration (2025 · Nature Communications · 被引 22)
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer (2025 · Cancer Discovery · 被引 20)
Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma (2025 · Molecular Cell · 被引 15)
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs (2025 · Nature Chemical Biology · 被引 14)
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor (2024 · Journal of Medicinal Chemistry · 被引 9)
MYC amplification and MYC protein expression are poor prognostic markers in pediatric and young adult osteosarcoma (2025 · Cancer · 被引 5)